Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study. (December 2022) - Foo, V.V.; Pang, I.X.; Shu, F.E.P.; Fong, A.Y.Y.; Chen, L.S.; Ho, K.H.; Ling, H.S.; Bhavnani, C.D.; Thien, L.K.; Chung, B.K.; Oon, Y.Y.; Koh, K.T.; et al.